"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

DEADLINE EXTENDED!!!

DEADLINE EXTENDED!!!

Apply to Present – Please complete your application prior to August 28, 2018.

Thank you for your interest in applying to present your company to our audience of targeted investors, VCs, and potential partners at the 2018 Southeast BIO Investor & Partnering Forum.

read more

Registration Open for SEBIO 2018!!

Registration Open for SEBIO 2018!!

Celebrating its 20th Anniversary, the Southeast BIO Investor & Partnering Forum returns to Atlanta on November 13-14, 2018 with a new format, new networking opportunities, and new investment prospects.

read more

Lacerta Therapeutics, Inc. Closes On $30 million Investment Round

Lacerta Therapeutics, Inc. Closes On $30 million Investment Round

UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on a $30 million investment round. Lacerta is a clinical-stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous system and lysosomal storage diseases.

read more